The latest buzz is around a way to achieve weight loss, without the extreme negative effects, by micro-dosing the drug ... (in the States, the FDA has approved them to help tackle obesity). A clinical ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Kentucky, Alaska and Alabama are the three states where weight loss drugs are most used, and Hawaii, Arizona and Colorado sit at the other end of the spectrum, a report has revealed.

She could go to a med-spa, but that would cost about $1,000 a month, still too much for the new therapist ... it became the ...

European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...

GoodRx has officially entered the weight loss drug market by offering an exclusive discount on the once-daily oral medication Qsymia.